Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-14
1995-07-25
Haley, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514299, 514304, 514319, A61K 31445
Patent
active
054362555
ABSTRACT:
3-Piperidino-1-chromanol derivatives and analogs having the formula ##STR1## wherein A and B are taken together and are --CH.sub.2 CH.sub.2 -- or A and B are taken separately and are each H;
REFERENCES:
patent: 3294804 (1966-12-01), Carabateas
patent: 3509164 (1970-04-01), Carron et al.
patent: 4016281 (1977-04-01), Jonas et al.
patent: 4048317 (1977-09-01), Watts
patent: 4082755 (1978-04-01), van Wijngaarden
patent: 4304915 (1981-12-01), Berthold
patent: 4358456 (1982-11-01), Ward
patent: 4393069 (1983-07-01), Langbein et al.
patent: 4446113 (1984-05-01), Evans et al.
patent: 4610992 (1986-09-01), Evans et al.
patent: 4640928 (1987-02-01), Willcocks
patent: 4902695 (1990-02-01), Ornstein
patent: 5034401 (1991-07-01), Frost et al.
patent: 5187162 (1993-02-01), Marangos et al.
patent: 5192751 (1993-03-01), Thor
patent: 5352683 (1994-10-01), Mayer
Hansen and Krogsgaard-Larsen, Med. Res. Rev., 10, pp. 55-94 (1990).
Murphy et al., British J. Pharmacol., 95, pp. 932-938 (1988).
Abstract 86:189738m (1977) Chemical Abstracts, vol. 86.
Harrison and Simmonds, British J. Pharmacol., 84, pp. 381-391 (1985).
Schoepp et al., J. Neur. Transm., 85, pp. 131-143 (1991).
R. S. McLachlan, Can. J. Neurol. Sci., 19 (4), p. 487, (1992). (Abstract Only).
Carron et al., Arneim-Forsch., vol. 21, pp. 1992-1998 (1971).
Trujillo and Akil, Science, 251, p. 85, (1991).
Bonte et al., Eur. J. Med. Chem., 25(4), pp. 361-368 (1990).
J. Lehmann et al., PIPS, 11, p. 1, (1990).
J. Lehmann, "The NMDA Receptor", Drugs of the Future, 14, No. 11, pp. 1059-1071, (1989).
Chemical Abstracts 89, 43498 (1978).
Chemical Abstracts 89, 146938W (1978).
Carter, et al., J. Pharmacology & Experimental Therapeutics 247, 1222 (1988).
Gotti, et al., J. Pharmacology & Experimental Therapeutics 247, 1211 (1988).
Benson Gregg C.
Brokke Mervin E.
Haley Jacqueline
Pfizer Inc.
Richardson Peter C.
LandOfFree
Method of treating diseases susceptable to treatment by blocking does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating diseases susceptable to treatment by blocking, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating diseases susceptable to treatment by blocking will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-739833